Gerber Hans-Peter — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Gerber Hans-Peter is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $14K.
Profile
Hans-Peter Gerber is the Chief Scientific Officer at Sutro Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation protein therapeutics. He has been involved in the company's drug discovery and development efforts, particularly in oncology and autoimmune disorders.
Role
Insider
Notability
30/100
Board memberships
Sutro Biopharma, Inc.
Awards & honors
Chief Scientific Officer at Sutro Biopharma
Contributed to the development of STRO-001 and STRO-002
Hans-Peter Gerber is the Chief Scientific Officer at Sutro Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation protein therapeutics. He has been involved in the company's drug discovery and development efforts, particularly in oncology and autoimmune disorders.…
Has Gerber Hans-Peter been buying or selling stock?
Recorded transactions: 1 open-market purchases ($14K) and 0 open-market sales () across all tracked filings.
Where can I see all of Gerber Hans-Peter's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
